Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Beta Bionics, Inc. - Common Stock (NQ:BBNX)

17.58 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Beta Bionics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors of Substantial Losses to a Securities Class Action - Critical Deadline is November 3, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
Beta Bionics (NASDAQ:BBNX) Slides After Q3 Results as Guidance and Product Timing Weigh ↗
Via Chartmill
News headline image
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Lawsuit – Deadline is November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Beta Bionics (BBNX) Q3 2026 Earnings Call Transcript ↗
Revenue hit $35.5 million with 30% growth as Mint patch pump nears Q1 2027 launch. 
Via The Motley Fool
Topics Earnings
News headline image
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Beta Bionics Q3 Earnings Call Highlights ↗
Beta Bionics (NASDAQ:BBNX) reported third-quarter net sales of $35.5 million, up about 30% from a year earlier, as new patient starts and recurring revenue from its pharmacy-channel user base supported... 
Via MarketBeat
Topics Earnings
After-Hours Market Movers for Oct. 27, 2026: Gainers and Losers ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
From Pomerantz LLP
Via GlobeNewswire
News headline image
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
From Beta Bionics, Inc.
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Beta Bionics, Inc. Investors They Have Until November 3rd to Seek Lead Plaintiff Role with The Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Beta Bionics (BBNX) To Contact Him Directly To Discuss Their Options 
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Pending Securities Class Action Deadline on November 3, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action Notice - Contact SueWallSt
A securities class action alleges Beta Bionics kept a June 2025 FDA Form 483 and more than 18,000 unreported iLet complaints out of public view for months, with the dates of each disclosure tracking a... 
From SueWallSt
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); Hub Group, Inc. (NASDAQ: HUBG); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Kaplan Fox Announces a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) – Lead Plaintiff Deadline is November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
BBNX Deadline Alert: Levi & Korsinsky Reminds Beta Bionics, Inc. (BBNX) Investors of Securities Class Action Deadline on November 3, 2026
A securities class action alleges Beta Bionics assured shareholders that an FDA Form 483 was a "very benign" reporting technicality, and investor confidence held for months until the agency's Warning... 
From Levi & Korsinsky, LLP
Via GlobeNewswire
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
BBNX Investor Alert: Beta Bionics, Inc. Stockholders with Large Losses Should Contact Robbins LLP About Leading the Securities Class Action Lawsuit
San Diego, California--(Newsfile Corp. - October 23, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased... 
Via Newsfile
Topics Lawsuit
News headline image
Kaplan Fox Encourages Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Act Ahead of the Lead Plaintiff Deadline on November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
BBNX Shareholder Alert: Beta Bionics, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
From SkyMedia, LLC
Via GlobeNewswire
News headline image
Kaplan Fox Urges Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to Seek a Leadership Role Before November 3, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
From Schall, Brown & Schwartz LLP
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your
From Grabar Law Office
Via GlobeNewswire
News headline image
BETA BIONICS, INC. (BBNX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Beta Bionics, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Beta Bionics, Inc. (NASDAQ: BBNX) on November 3, 2026
From Kaplan Fox & Kilsheimer, LLP
Via GlobeNewswire
News headline image
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
BBNX ALERT: Bragar Eagel & Squire, P.C. Urges Beta Bionics, Inc. Investors to Contact the Firm Regarding Their Rights
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.